Uveitis and scleritis associated with bisphosphonates.
Tacrolimus and apraxia.
Drug Safety News:
Parenteral administration of bisphosphonates and osteonecrosis of the jaw (8/11/2005).
Galantamine (Reminyl®): mortality in patients with mild cognitive impairment. Updated information from the informative note 2005/02 of the Spanish Agency for Medicines and Health Products (24/10/2005).
Precautionary suspension of the marketing authorization for Hexavac® (hexavalent vaccine) (20/09/2005).